A previous study revealed that Lactobacillus could produce anti-oxidant enzymes to alleviate intestinal inflammation and oxidative stress, ameliorating inflammatory bowel disease by modulating the Nrf2 and MAPK signalling pathways [28]. The gene discussed is NFE2L2; the disease is inflammatory bowel disease.